Mayflower Bioscience

Mayflower Bioscience Overview

Status Private
Employees 3
Latest Deal Type Accelerator/​Inc
Investors 1

Mayflower Bioscience General Information


Developer of biological reagents and assays intended to accelerate biological research and drug discovery. The company's product line include antibody products, assays, kits and compounds, cell and tissue products and dna amplification kits, enabling research organizations mainly European life science companies to advance their important research programs such as biological research drug delivery and bioproduction.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • Helix Center
  • 1100 Corporate Square Drive
  • Saint Louis, MO 63132
  • United States
+1 (314) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mayflower Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jun-2012 Completed Startup

Mayflower Bioscience Executive Team (2)

Name Title Board Seat Contact Info
Umesh Patel Ph.D Chief Executive Officer & Co-Founder
Mark Keck Chief Commercial Officer,Business development, Director& Co-founder

Mayflower Bioscience Investors (1)

To view Mayflower Bioscience‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Helix Center Biotech Incubator Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial